Medpace Holdings ROE 2014-2023 | MEDP
Medpace Holdings ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2023-12-31 | $0.28B | $0.56B | 64.03% |
2023-09-30 | $0.27B | $0.47B | 68.71% |
2023-06-30 | $0.27B | $0.39B | 73.00% |
2023-03-31 | $0.26B | $0.35B | 75.26% |
2022-12-31 | $0.25B | $0.39B | 60.34% |
2022-09-30 | $0.23B | $0.35B | 41.26% |
2022-06-30 | $0.21B | $0.28B | 30.52% |
2022-03-31 | $0.20B | $0.61B | 24.18% |
2021-12-31 | $0.18B | $0.95B | 20.44% |
2021-09-30 | $0.18B | $0.90B | 21.32% |
2021-06-30 | $0.17B | $0.85B | 21.03% |
2021-03-31 | $0.16B | $0.86B | 19.78% |
2020-12-31 | $0.14B | $0.81B | 18.86% |
2020-09-30 | $0.12B | $0.79B | 16.68% |
2020-06-30 | $0.11B | $0.74B | 14.89% |
2020-03-31 | $0.11B | $0.72B | 15.75% |
2019-12-31 | $0.10B | $0.73B | 14.83% |
2019-09-30 | $0.09B | $0.69B | 14.36% |
2019-06-30 | $0.09B | $0.66B | 14.32% |
2019-03-31 | $0.08B | $0.62B | 13.32% |
2018-12-31 | $0.07B | $0.59B | 13.26% |
2018-09-30 | $0.06B | $0.56B | 11.72% |
2018-06-30 | $0.05B | $0.54B | 10.07% |
2018-03-31 | $0.05B | $0.51B | 8.47% |
2017-12-31 | $0.04B | $0.50B | 6.84% |
2017-09-30 | $0.03B | $0.55B | 4.69% |
2017-06-30 | $0.02B | $0.61B | 3.76% |
2017-03-31 | $0.02B | $0.62B | 3.91% |
2016-12-31 | $0.01B | $0.61B | 4.26% |
2016-06-30 | $0.01B | $0.00B | inf% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.032B | $1.886B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $122.851B | 15.41 |
Cencora (COR) | United States | $47.686B | 19.03 |
ICON (ICLR) | Ireland | $24.574B | 23.20 |
DiDi Global (DIDIY) | China | $24.011B | 0.00 |
Avantor (AVTR) | United States | $16.459B | 24.23 |
Viatris (VTRS) | United States | $13.776B | 3.96 |
CochLear (CHEOY) | Australia | $13.705B | 0.00 |
Revvity (RVTY) | United States | $12.658B | 22.18 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.086B | 0.00 |
Charles River Laboratories (CRL) | United States | $11.796B | 21.50 |
Natera (NTRA) | United States | $11.354B | 0.00 |
Solventum (SOLV) | United States | $11.215B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
HealthEquity (HQY) | United States | $6.770B | 50.58 |
Bausch + Lomb (BLCO) | Canada | $5.109B | 19.65 |
Organon (OGN) | United States | $4.786B | 4.61 |
Doximity (DOCS) | United States | $4.531B | 33.74 |
PACS (PACS) | United States | $3.749B | 0.00 |
Surgery Partners (SGRY) | United States | $3.171B | 29.35 |
Sotera Health (SHC) | United States | $3.170B | 15.56 |
Progyny (PGNY) | United States | $3.081B | 51.71 |
GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
Life Times (LTH) | United States | $2.687B | 29.70 |
Premier (PINC) | United States | $2.502B | 9.16 |
AMN Healthcare Services Inc (AMN) | United States | $2.273B | 7.35 |
Agilon Health (AGL) | United States | $2.261B | 0.00 |
Teladoc Health (TDOC) | United States | $2.162B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.830B | 0.00 |
Agiliti (AGTI) | United States | $1.381B | 22.56 |
Establishment Labs Holdings (ESTA) | $1.373B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.317B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.982B | 0.00 |
Pediatrix Medical (MD) | United States | $0.745B | 7.71 |
Embecta (EMBC) | United States | $0.583B | 3.85 |
COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
Enhabit (EHAB) | United States | $0.506B | 45.86 |
Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
LifeMD (LFMD) | United States | $0.488B | 0.00 |
InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.445B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.437B | 0.00 |
MultiPlan (MPLN) | United States | $0.419B | 0.00 |
CareDx (CDNA) | United States | $0.402B | 0.00 |
Beauty Health (SKIN) | United States | $0.399B | 0.00 |
Sera Prognostics (SERA) | United States | $0.379B | 0.00 |
DocGo (DCGO) | United States | $0.352B | 56.33 |
ModivCare (MODV) | United States | $0.333B | 4.42 |
Ascend Wellness Holdings (AAWH) | United States | $0.304B | 0.00 |
Sharecare (SHCR) | United States | $0.259B | 0.00 |
Biodesix (BDSX) | United States | $0.142B | 0.00 |
So-Young (SY) | China | $0.129B | 43.33 |
Oncology Institute (TOI) | United States | $0.079B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.030B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |